Advertisement

Table of Contents

January 01, 1988; Volume 33,Issue 1

You have access
Cardiotonic agents. 3. A topographical model of the cardiac cAMP phosphodiesterase receptor.
P W Erhardt, A A Hagedorn and M Sabio

Molecular Pharmacology January 1988, 33 (1) 1-13;
You have access
Immunohistochemical demonstration of isozyme- and strain-specific differences in the intralobular localizations and distributions of UDP-glucuronosyltransferases in livers of untreated rats.
S A Knapp, M D Green, T R Tephly and J Baron

Molecular Pharmacology January 1988, 33 (1) 14-21;
You have access
Primary structures of multiple forms of cytochrome P-450 isozyme 2 derived from rabbit pulmonary and hepatic cDNAs.
R Gasser, M Negishi and R M Philpot

Molecular Pharmacology January 1988, 33 (1) 22-30;
You have access
Cytochrome P-450 b and c in the rat brain and pituitary gland.
B M Näslund, H Glaumann, M Warner, J A Gustafsson and T Hansson

Molecular Pharmacology January 1988, 33 (1) 31-37;
You have access
Synergism between histamine H1- and H2-receptors in the cAMP response in guinea pig brain slices: effects of phorbol esters and calcium.
M Garbarg and J C Schwartz

Molecular Pharmacology January 1988, 33 (1) 38-43;
You have access
Histamine receptors coupled to [3H]cAMP accumulation in brain: pharmacological characterization in a vesicular preparation of guinea pig cortex.
M N Gannon and L B Hough

Molecular Pharmacology January 1988, 33 (1) 44-50;
You have access
Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine.
R M McKernan, W R Strickland and P A Insel

Molecular Pharmacology January 1988, 33 (1) 51-57;
You have access
Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
W J Morrison and S D Shukla

Molecular Pharmacology January 1988, 33 (1) 58-63;
You have access
Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.
H P Too, W G Unger and M R Hanley

Molecular Pharmacology January 1988, 33 (1) 64-71;
You have access
Hydrophobicity of the tetrabenazine-binding site of the chromaffin granule monoamine transporter.
D Scherman, B Gasnier, P Jaudon and J P Henry

Molecular Pharmacology January 1988, 33 (1) 72-77;
You have access
Correlation of alpha- and beta-rotameric forms of 2-substituted octahydrobenzo[f]quinoline dopamine congeners with high and low affinity states of the anterior pituitary dopamine receptor and prolactin inhibition.
P R Findell, S M Torkelson, J C Craig and R I Weiner

Molecular Pharmacology January 1988, 33 (1) 78-83;
You have access
Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
D W Fry and J A Besserer

Molecular Pharmacology January 1988, 33 (1) 84-92;
You have access
The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?
G Meunier, D De Montauzon, J Bernadou, G Grassy, M Bonnafous, S Cros and B Meunier

Molecular Pharmacology January 1988, 33 (1) 93-102;
You have access
Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
J C Stevens and J Halpert

Molecular Pharmacology January 1988, 33 (1) 103-110;
You have access
Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the lobule in livers from untreated and 3-methylcholanthrene-treated rats.
J G Conway, F C Kauffman, T Tsukuda and R G Thurman

Molecular Pharmacology January 1988, 33 (1) 111-119;
You have access
Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
K S Korach, P Sarver, K Chae, J A McLachlan and J D McKinney

Molecular Pharmacology January 1988, 33 (1) 120-126;